Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar erictao (48.08) Submitted: 12/22/2006 3:02:58 PM : Outperform Start Price: $4.98 PCYC Score: +559.31

In the right domain and has substaintail for growth

Featured Broker Partners


Advertisement